Login
$NAUT
$2.89 +$0.45 (18.44%) Close

$NAUT 8-K/A SEC Filings

Filed On Filing
01 Nov 2022 8-K/A: Departure/Election of Directors or Officers; Compensation

This Amendment No. 1 to Current Report on Form 8-K/A (the “Amendment”) amends the Current Report on Form 8-K of Nautilus Biotechnology, Inc. (the “Company”) dated March 30, 2022 and filed with the Commission on March 31, 2022 (the “Origi...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support